Absolute 10-y fracture risk based on multiple factors is the preferred method for risk assessment. A simplified risk assessment system from sex, age, DXA, and two clinical risk factors (CRFs) prior fracture and systemic corticosteroid (CS) use has been used in Canada since 2005. This study [1] was undertaken to evaluate this system in the Canadian female population. A total of 16205 women >50 y of age at the time of baseline BMD (1998–2002) were identified in a database containing all clinical DXA test results for the Province of Manitoba, Canada. Basal 10-yr fracture risk from age and minimum T-score (lumbar spine, femur neck, trochanter, total hip) was categorized as low (<10%), moderate (10–20%), or high (>20%).
Read the rest of this entry »
A simple risk score for the assessment of absolute fracture risk in general practice
02/02/2010 in DiagnosisThe aim of this prospective study [1] was to develop a risk score, based on putative risk factors in current guidelines, which can be used to identify women at high risk of fractures in general practice. The study sample included 4157 women >60 y of age (mean ± SD: 74.1 ± 9.1 yr), with a median follow-up of 8.9 y of the Rotterdam Study (ERGO), and 762 women >65 y of age (mean ± SD: 76.0 ± 6.7.y), with a median follow-up of 6.0 y of the Longitudinal Aging Study Amsterdam (LASA). Potential risk factors were those proposed in risk scores of three recent guidelines on osteoporosis: age, family history of fractures, prior fracture, low body weight/body mass index (BMI), serious immobility, rheumatoid arthritis, current smoking, alcohol consumption >2 units daily, prevalent vertebral fracture, and systemic corticosteroid use.
Age-related osteoporosis is characterized by low bone mass, poor bone quality, and impaired osteoblastogenesis. Recently, the Hutchinson-Gilford progeria syndrome (HGPS), a disease of accelerated aging and premature osteoporosis, has been linked to mutations in the gene encoding for the nuclear lamina protein lamin A/C. Here [1], the authors tested the hypothesis that inhibition of lamin A/C in osteoblastic lineage cells impairs osteoblastogenesis and accelerates osteoclastogenesis. Lamin A/C was knockeddown with small interfering (si)RNA molecules in human bone marrow stromal cells (BMSCs) differentiating toward osteoblasts.
Quantitative ultrasound has been shown to predict risk of fracture in various populations. However, this ability may be modified by the presence of previous fracture in very frail older people. The authors of a recent study [1] assessed bone strength by quantitative ultrasound (QUS) and clinical risk factors at baseline for 1 982 institutionalised older people. Fractures were ascertained for 2 years from baseline and validated by X-ray reports.
Management of osteoporosis with FRAX: assessment and intervention thresholds for the UK
07/07/2009 in DiagnosisThe fracture risk assessment tool (FRAX®) tool has recently become available to compute the 10-year probability of fractures in men and women from clinical risk factors (CRFs) with or without the measurement of femoral neck bone mineral density (BMD). The aim of this study [1] was to develop a case-finding strategy for men and women from the UK at high risk of osteoporotic fracture by delineating the fracture probabilities at which BMD testing or intervention should be recommended. Fracture probabilities were computed using the FRAX® tool calibrated to the epidemiology of fracture and death in the UK. An intervention threshold was set by age in men and women, based on the fracture probability equivalent to that of women with a history of a prior osteoporosis-related fracture. In addition, assessment thresholds for the use of BMD testing were explored. Assessment thresholds for the measurement of BMD followed current practice guidelines where individuals were considered to be eligible for assessment in the presence of one or more CRF. An upper assessment threshold (ie, a fracture probability above which patients could be treated without recourse to BMD), was based on optimization of the positive predictive value of the assessment tool. The consequences of assessment and intervention thresholds on the requirement for BMD test and interventions were assessed using the distribution of clinical risk factors and femoral neck BMD for women in the source cohorts used for the development of the FRAX® models.
Read the rest of this entry »
Bone loss, weight loss, and weight fluctuation predict mortality risk in elderly men and women
09/06/2009 in DiagnosisBone mineral density (BMD) is a dynamic variable and is known to decline with advancing age. Although it has been shown that either low BMD or the greater the difference between two measurements in BMD is associated with all-cause mortality in women, it is not known whether the rate of BMD loss contributes to mortality risk independent of baseline BMD. Furthermore, the associations between BMD and bone loss and mortality in men have not been studied. Body weight is strongly related to BMD, such that higher weight is associated with higher BMD and reduced fracture risk. Although it was suggested that weight loss and weight fluctuation are associated with an increased risk of mortality, it is unknown whether the effect of weight loss or weight fluctuation on mortality is independent of baseline BMD and rate of bone loss. To answer these questions, a recent study [1] collected data from 1059 women and 644 men, older than 60 (as of 1989), of white background. All-cause mortality was recorded annually between 1989 and 2004. BMD at the femoral neck was measured by DXA at baseline and at approximately every 2 yr afterward. Data on incident osteoporotic fractures and concomitant diseases, including cardiovascular diseases, all types of cancer, and type I/II diabetes mellitus, was also recorded.
Read the rest of this entry »
A real bone mineral density (aBMD) at the distal radius can predict subsequent wrist fractures, but the actual basis for this association is uncertain. In particular, it is not clear whether fracture risk is determined by BMD per se or by some related parameter. Previously available technologies allowed some assessment of bone size (a confounder of aBMD) and geometry. However, it is now possible to explore this issue in more detail using high-resolution peripheral quantitative computerized tomography (pQCT), which can measure numerous micro- and macrostructural variables in the distal radius, along with volumetric BMD (vBMD) of cortical and trabecular bone separately. The purpose of this report [1] was to evaluate these diverse measures (BMD, bone geometry, bone microstructure, bone strength, and fall load to bone strength ratios) in a population sample of postmenopausal women with and without a prior distal forearm (Colles’) fracture (n=18 in each group).
Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women
17/02/2009 in DiagnosisDespite the sexual dimorphism of bone, hip fracture risk is very similar in men and women at the same absolute bone mineral density (BMD). A recent study was conducted with the objective of elucidating the main structural properties of bone that underlie the measured BMD and that ultimately determine the risk of hip fracture in elderly men and women [1]. This study is part of the Rotterdam Study (a large prospective population-based cohort) and included 147 incident hip fracture cases in 4806 participants with DXA-derived hip structural analysis (mean follow-up, 8.6 y).
Read the rest of this entry »
Serum biomarker profile associated with high bone turnover and BMD in postmenopausal women
09/12/2008 in DiagnosisEarly diagnosis of onset osteoporosis is essential for the delivery of effective therapy. Biochemical markers of bone turnover provide a means of evaluating skeletal dynamics that complements static measurements of bone mineral density (BMD) by dual energy X-ray absorptiometry. Conventional clinical measurements of bone turnover, primarily the estimation of collagen and its breakdown products in the blood or urine, lack both sensitivity and specificity as a reliable diagnostic tool. In this study [1], the serum proteome of 58 postmenopausal women with high or low/normal bone turnover (training set) was analyzed by surface-enhanced laser-desorption/ionization time-of-flight (SELDI-TOF) mass spectrometry, and a diagnostic fingerprint was identified using a variety of statistical and machine-learning tools. The diagnostic fingerprint was validated in a separate test set, consisting of serum samples from an additional 59 postmenopausal women obtained from the same Mayo cohort, with a gap of 2 y.
European guidance for the diagnosis and management of osteoporosis in postmenopausal women - Therapeutic interventions and monitoring
02/12/2008 in DiagnosisOsteoporosis is defined as a systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, with a consequent increase in bone fragility and susceptibility to fracture. Although the diagnosis of the disease relies on the quantitative assessment of bone mineral density (BMD), which is a major determinant of bone strength, the clinical significance of osteoporosis lies in the fractures that arise.
Most used keywords
β-catenin age BMD bone bone density bone density test bone formation bone fracture bone loss bone marrow bone remodeling bone resorption bone strength breast cancer calcium cardiovascular cardiovascular disease cell cell bone marrow cholesterol Clinical data diabetes disease epidemiology fracture fracture risk FRAX heart heart disease hip fracture mesenchymal stem cells neuromedin U osteoblast osteoblast differentiation osteoclast osteoporosis osteoprotegerin osterix ovariectomy RANKL residual lifetime risk risk factors sclerotin survival weight loss